PMID: 11922955Mar 30, 2002Paper

Computer systems for the prediction of xenobiotic metabolism

Advanced Drug Delivery Reviews
J J Langowski, Anthony Long

Abstract

The aim of pharmaceutical research and development is to ensure a continuing pipeline of new chemical entities (NCEs) displaying high therapeutic efficacy with few or no side effects. Failure of promising lead candidates late in the drug discovery processes is regarded as commercially unacceptable in today's increasingly competitive business environment. An inappropriate ADME/Toxicity profile in humans is the major cause of failure of lead candidates in late clinical stages of drug development. Combinatorial chemistry techniques coupled with high throughput screening protocols means that pharmaceutical companies are now dealing with an unprecedented number of NCEs on an annual basis. As a consequence, screening for undesirable ADME/Toxicity properties in the early stages of drug development, preferably pre-synthesis, is now considered the essential paradigm. In silico assessment of NCEs is rapidly emerging as the next wave of technology for early ADME/Toxicity prediction. In this review, we discuss the major commercially available products for the assessing the potential metabolic activity of xenobiotic substances in mammalian systems.

References

Apr 15, 1976·Biochemical Pharmacology·E Mezey
Nov 1, 1994·Journal of Chemical Information and Computer Sciences·G KlopmanJ Talafous
Nov 1, 1994·Journal of Chemical Information and Computer Sciences·J TalafousG Klopman
Jul 1, 1996·Journal of Chemical Information and Computer Sciences·P N JudsonP J Krause
Sep 24, 1999·SAR and QSAR in Environmental Research·N GreeneC A Marchant

❮ Previous
Next ❯

Citations

Jan 25, 2008·Journal of Computer-aided Molecular Design·John H Block, Douglas R Henry
Sep 10, 2003·Drug Discovery Today·Hongshi Yu, Adedayo Adedoyin
Sep 3, 2013·Journal of Chemical Information and Modeling·Lochana C MenikarachchiDavid F Grant
Mar 4, 2003·Nature Reviews. Drug Discovery·Han van de Waterbeemd, Eric Gifford
Mar 11, 2011·SAR and QSAR in Environmental Research·T Peyret, K Krishnan
Feb 17, 2005·Bioinformatics·Svava Osk JónsdóttirSøren Brunak
Mar 17, 2009·Bioinformatics·Mingyue ZhengHualiang Jiang
Dec 31, 2005·Nucleic Acids Research·Lynda B M EllisLawrence P Wackett
Jul 22, 2011·Journal of Bioinformatics and Computational Biology·Reiji Teramoto, Tsuyoshi Kato
Jun 10, 2003·Clinical Pharmacokinetics·Collen M MasimirembwaTommy B Andersson
Aug 26, 2014·Assay and Drug Development Technologies·Jonathan J CherryJill Jarecki
Jun 23, 2010·Expert Opinion on Drug Metabolism & Toxicology·Roy J VazGabriele Cruciani
Jul 25, 2006·Expert Opinion on Drug Metabolism & Toxicology·Judith C Madden, Mark T D Cronin
Jan 1, 2008·Toxicology Mechanisms and Methods·Carol A MarchantAnthony Long
Feb 15, 2003·Journal of Pharmaceutical Sciences·Joseph V TurnerSnezana Agatonovic-Kustrin
Aug 9, 2007·Journal of Molecular Graphics & Modelling·Yojiro SakiyamaTeruki Honma
Dec 29, 2006·Chemistry & Biodiversity·Bernard TestaPhilip Judson
Sep 19, 2009·Molecular Nutrition & Food Research·Claudine ManachAugustin Scalbert
Nov 18, 2008·Chemical Biology & Drug Design·Mahnaz Esteki, Taghi Khayamian
Nov 3, 2009·Chemical Biology & Drug Design·Hao Sun, Dennis O Scott
Jun 4, 2005·Drug Metabolism Reviews·David S Wishart
May 28, 2003·Journal of Chemical Information and Computer Sciences·Bo Kyeng HouLynda B M Ellis
Sep 23, 2003·Journal of Chemical Information and Computer Sciences·Yu BorodinaV Poroikov
Mar 7, 2013·Drug Metabolism Reviews·Satya Prakash TripathiAbhay T Sangamwar
Dec 29, 2006·Chemistry & Biodiversity·Bernard Testa, Stefanie D Krämer
Aug 23, 2006·Expert Opinion on Drug Metabolism & Toxicology·Sean EkinsTatiana Nikolskaya
Nov 12, 2013·Expert Opinion on Drug Metabolism & Toxicology·Ana CostaVítor Seabra
Aug 23, 2006·Expert Opinion on Drug Metabolism & Toxicology·Han Van de Waterbeemd
Nov 5, 2011·Expert Opinion on Drug Metabolism & Toxicology·Florian NigschJeremy L Jenkins
May 18, 2005·Drug Discovery Today·M Reza Anari, Thomas A Baillie
Nov 30, 2013·Regulatory Toxicology and Pharmacology : RTP·Jos G BessemsJosé-Manuel Zaldívar-Comenges
Feb 25, 2015·Journal of Computer-aided Molecular Design·Ignacio AliagasS Cyrus Khojasteh
Jul 13, 2004·Journal of Industrial Microbiology & Biotechnology·Bo Kyeng HouLawrence P Wackett
Jun 15, 2016·International Journal of Molecular Sciences·Serena NembriRoberto Todeschini
Sep 11, 2018·Critical Reviews in Biotechnology·Arun Kumar DangiPratyoosh Shukla

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Chemical Information and Computer Sciences
Yu BorodinaV Poroikov
Journal of Chemical Information and Computer Sciences
J TalafousG Klopman
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
S A KulkarniS Blechinger
Expert Opinion on Drug Metabolism & Toxicology
Sean EkinsTatiana Nikolskaya
Journal of Chemical Information and Computer Sciences
G KlopmanJ Talafous
© 2022 Meta ULC. All rights reserved